Covered recipient · General Payments record
MOE HEIN AUNG
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2022–2025
$1,679.64
- Reported across 46 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $597.48 | 18 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $208.12 | 10 |
| GLAUKOS CORPORATION | $207.55 | 2 |
| ARGENX US, INC. | $74.55 | 1 |
| Amgen Inc. | $61.19 | 3 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $31.19 | 1 |
| Harrow Eye, LLC | $14.88 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $18.34 | 02/21/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201444693 | CMS |
| ABBVIE INC. | $7.97 | 03/11/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201444695 | CMS |
| ABBVIE INC. | $34.82 | 03/13/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201444697 | CMS |
| ABBVIE INC. | $31.24 | 04/08/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201444699 | CMS |
| ABBVIE INC. | $14.03 | 07/11/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201444701 | CMS |
| ABBVIE INC. | $18.49 | 08/22/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201444703 | CMS |
| ABBVIE INC. | $15.50 | 10/22/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201444705 | CMS |
| ABBVIE INC. | $20.46 | 11/07/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201444707 | CMS |
| ABBVIE INC. | $17.73 | 12/10/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201444709 | CMS |
| ABBVIE INC. | $29.54 | 12/15/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201444711 | CMS |
| Amgen Inc. | $15.77 | 01/28/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228672645 | CMS |
| Amgen Inc. | $23.82 | 09/08/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228672643 | CMS |
| Amgen Inc. | $21.60 | 12/03/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228672641 | CMS |
| ARGENX US, INC. | $74.55 | 03/17/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1240431998 | CMS |
| Glaukos Corporation | $178.21 | 05/15/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1246402431 | CMS |
| Glaukos Corporation | $29.34 | 09/30/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1246402481 | CMS |
| Harrow Eye, LLC | $14.88 | 05/15/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1236211323 | CMS |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $31.19 | 09/23/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1251038838 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2022, 2023, 2024, 2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.